about
Direct-to-consumer stem cell marketing and regulatory responsesThe unregulated commercialization of stem cell treatments: a global perspective.Marketing of unproven stem cell-based interventions: A call to action.The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies.'No one here's helping me, what do you do?': addressing patient need for support and advice about stem cell treatments.Identity and ownership issues in the regulation of autologous cells.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stem cell stratagems in alternative medicine.
@en
Stem cell stratagems in alternative medicine.
@nl
type
label
Stem cell stratagems in alternative medicine.
@en
Stem cell stratagems in alternative medicine.
@nl
prefLabel
Stem cell stratagems in alternative medicine.
@en
Stem cell stratagems in alternative medicine.
@nl
P2860
P356
P1476
Stem cell stratagems in alternative medicine
@en
P2093
Douglas Sipp
P2860
P304
P356
10.2217/RME.11.13
P50
P577
2011-03-31T00:00:00Z